Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis.
about
Efficacy of strain RB51 vaccine in protecting infection and vertical transmission against Brucella abortus in Sprague-Dawley ratsComplementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation.Protective properties of rifampin-resistant rough mutants of Brucella melitensisEffects of exogenous recombinant interleukin-12 on immune responses and protection against Brucella abortus in a murine model.Complement fixation test to assess humoral immunity in cattle and sheep vaccinated with Brucella abortus RB51.Characterization of specific immune responses of mice inoculated with recombinant vaccinia virus expressing an 18-kilodalton outer membrane protein of Brucella abortus.O-Polysaccharide epitopic heterogeneity at the surface of Brucella spp. studied by enzyme-linked immunosorbent assay and flow cytometryVaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide dismutase protects mice against virulent B. abortusProtection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MDeltapurEK).Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cellsInduction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51.Mouse cytokine profiles associated with Brucella abortus RB51 vaccination or B. abortus 2308 infectionA DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c miceCaspase-2-dependent dendritic cell death, maturation, and priming of T cells in response to Brucella abortus infection.Characterization and protective property of Brucella abortus cydC and looP mutants.Deletion of znuA virulence factor attenuates Brucella abortus and confers protection against wild-type challengeEvaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice.Oral vaccination with Brucella melitensis WR201 protects mice against intranasal challenge with virulent Brucella melitensis 16M.Brucella abortus RB51 induces protection in mice orally infected with the virulent strain B. abortus 2308.Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model.Comparison of spleen cell proliferation in response to Brucella abortus 2308 lipopolysaccharide or proteins in mice vaccinated with strain 19 or RB51.Lymphocyte proliferation in response to Brucella abortus RB51 and 2308 proteins in RB51-vaccinated or 2308-infected cattle.Antibody responses to Brucella abortus 2308 in cattle vaccinated with B. abortus RB51Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosisImmune responses and resistance to brucellosis in mice vaccinated orally with Brucella abortus RB51Characterization of smooth lipopolysaccharides and O polysaccharides of Brucella species by competition binding assays with monoclonal antibodies.Lymphocyte proliferative responses of goats vaccinated with Brucella melitensis 16M or a delta purE201 strain.Protection against infection in mice vaccinated with a Brucella abortus mutant.What have we learned from brucellosis in the mouse model?Meta-Analysis and Advancement of Brucellosis Vaccinology.Vaxar: A Web-Based Database of Laboratory Animal Responses to Vaccinations and Its Application in the Meta-Analysis of Different Animal Responses to Tuberculosis Vaccinations.Ontology representation and analysis of vaccine formulation and administration and their effects on vaccine immune responsesIntraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of Brucella abortus induces SOD-specific CD4+ and CD8+ T cellsInfection outcome and cytokine gene expression in Brugia pahangi- infected gerbils (Meriones unguiculatus) sensitized with Brucella abortus.Brucella abortus ΔrpoE1 confers protective immunity against wild type challenge in a mouse model of brucellosis.Interaction of Brucella suis and Brucella abortus rough strains with human dendritic cells.
P2860
Q33569165-4B6ECCF8-C12B-41AF-99AD-A78E2328498EQ33596260-5B0AC1ED-1581-4F80-AC60-EB8D825C90C3Q33883263-28436310-1D1E-4D54-8D1F-5466C19E60D8Q33923914-14F86E57-E842-4645-A709-6421D1C33C6DQ33997946-3074FDE5-C516-4F92-B2A0-95ACE28AACCAQ33998168-765A92EF-CA31-4EB1-BAD7-9B7A0E5051C8Q33999640-925A31D8-0D83-4D25-838F-39C62B10193CQ34000475-E5A9274C-EB61-4DE2-9061-1CE3BB0BE64FQ34002465-FC195CB0-1FBA-4EA7-B994-D1267EEE4003Q34004642-E2E01417-A1F7-4CEE-AE46-71E98DD5BD39Q34008332-2A12DAB8-939F-43C7-A790-7990017A58C1Q34008913-0281A041-3B0F-4DBE-95D7-1CF6F79CC7FAQ34009498-CCF6A219-863A-4961-993C-C9EFA17A4C8BQ34121062-7A3B6547-AF3B-4DF6-A003-9A29DC1D4306Q34395763-EF9D244D-01B1-49C8-8E3D-7CDDF84976E0Q34593007-23E228C2-5C37-4FBC-8DC9-C1B55361F751Q34721093-7EAC72B2-CE49-4622-817A-F8CB926D6C82Q34721256-B7743C6A-9D39-4AC9-BE09-76470E988347Q34761388-05CEEA90-9FD9-4F02-B8D3-89EA0AB6AE93Q34932167-8C8A82FD-50CE-4977-8D88-9317286A1763Q35012958-19B1B9B2-C21D-4DD2-BAEF-113E273B07A5Q35432482-4F95D7FE-E847-4AE9-9511-2572C250D1FCQ35476799-3D85256B-A333-4312-A1D3-BBFC14F2D840Q35477059-1D1289F1-C7C6-42B9-B4E2-F677982A6A01Q35503256-EB24946C-1BD2-490E-A59B-0DA0B7A93A8CQ35528189-8D4D6833-491B-4FF6-B2F7-B4E8EE70E2AEQ35547483-C7798318-1A7F-4970-9727-A68C21C5B791Q35551850-985BB7FB-8CBD-403C-A1F9-C535A0621EDAQ35567731-3AF27E0F-73A9-4454-81DE-8CBC46716D1AQ36136716-175DA448-488C-4834-8564-B39E06E80E82Q36192841-9DA16B20-8BBB-4DCA-99FC-F9462F145F74Q36781749-B0EA7055-F84E-485A-A755-181EC8E10F04Q36803269-4A83C31F-2CAA-4509-9FAE-DE5BF9910C25Q37116700-6B66C01D-12E8-418E-8CD9-5783228E2745Q39663135-7BAB0D21-D5EC-46AB-9C2D-13724DFF81CEQ40552706-7D860475-9C12-4B35-883D-24FCCD5769D7Q42909728-40E7E991-325C-436C-842C-CB890B04254E
P2860
Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis.
description
1994 nî lūn-bûn
@nan
1994 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Vaccination with Brucella abor ...... melitensis, and Brucella ovis.
@ast
Vaccination with Brucella abor ...... melitensis, and Brucella ovis.
@en
Vaccination with Brucella abor ...... melitensis, and Brucella ovis.
@nl
type
label
Vaccination with Brucella abor ...... melitensis, and Brucella ovis.
@ast
Vaccination with Brucella abor ...... melitensis, and Brucella ovis.
@en
Vaccination with Brucella abor ...... melitensis, and Brucella ovis.
@nl
prefLabel
Vaccination with Brucella abor ...... melitensis, and Brucella ovis.
@ast
Vaccination with Brucella abor ...... melitensis, and Brucella ovis.
@en
Vaccination with Brucella abor ...... melitensis, and Brucella ovis.
@nl
P2093
P2860
P1476
Vaccination with Brucella abor ...... melitensis, and Brucella ovis
@en
P2093
Enright FM
Jiménez de Bagüés MP
Schurig GG
P2860
P304
P407
P577
1994-11-01T00:00:00Z